Effects of Autologous Serum Eye Drops on Conjunctival Expression of MUC5AC in Patients With Ocular Surface Disorders
Authors:
- Isabel García-LozanoIGIsabel García-Lozano
- Luis RivasLRLuis Rivas
- Carlos GiménezCGCarlos Giménez
- Arantxa AceraAAArantxa Acera
- Tatiana Suárez-CortésTSTatiana Suárez-Cortés
- 1 March 2016
- journal article
- Published by Wolters Kluwer Health in Cornea
- Vol. 35 (3) , 336-341
Abstract
To assess the effects of autologous serum eye drops on conjunctival expression of the mucin gene MUC5AC by means of quantitative reverse transcription polymerase chain reaction (RT-qPCR). A prospective and comparative interventional case series study of 38 eyes of 19 patients with different ocular surface disorders was performed before and 6 weeks after the treatment with autologous serum eye drops. All patients underwent a complete ophthalmic assessment, including evaluation of the tear film, ocular surface exploration, conjunctival impression cytology (IC), and MUC5AC detection by reverse transcription polymerase chain reaction. A total of 34 eyes were studied by IC and MUC5AC quantitative reverse transcription polymerase chain reaction before and after treatment with autologous serum. This treatment improved breakup time, conjunctival squamous metaplasia, goblet cell density, and subjective perception in 76.2%, 70.6%, 55.9% and 73.5% of eyes, respectively. Treatment with autologous serum enhanced conjunctival expression of MUC5AC (P = 0.001), although these differences were not statistically significant if data are analyzed patient by patient (P = 0.09). In 13 of 34 eyes (38.2%), we found increased expression of MUC5AC; in 12 eyes (35.3%), no significant changes were found; and in 9 eyes (26.5%), a decreased expression was found. The MUC5AC gene upregulation was related to the conjunctival involvement before treatment and with the improvement in the degree of squamous metaplasia and the increase in the number of goblet cells in IC after treatment (P = 0.001). Treatment with autologous serum enhances the conjunctival expression of MUC5AC by increasing the density of goblet cells, mainly in patients with severe conjunctival involvement.Keywords
This publication has 22 references indexed in Scilit:
- Novel Molecular Diagnostic System of Limbal Stem Cell Deficiency Based onMUC5ACTranscript Detection in Corneal Epithelium by PCR-Reverse Dot BlotInvestigative Ophthalmology & Visual Science, 2013
- Comparative Study of Limbal Stem Cell Deficiency Diagnosis Methods: Detection of MUC5AC mRNA and Goblet Cells in Corneal EpitheliumOphthalmology, 2012
- Ocular Features and Histopathologic Changes during Follow-up of Toxic Epidermal NecrolysisOphthalmology, 2011
- Autologous Serum Eyedrops in the Treatment of Aniridic KeratopathyOphthalmology, 2008
- Aplicaciones del suero autólogo en oftalmologíaArchivos de la Sociedad Española de Oftalmología, 2007
- Analysis of Corneal Surface Evolution After Moderate Alkaline Burns by Using Impression CytologyCornea, 2006
- Autologous serum application in the treatment of neurotrophic keratopathy*1Ophthalmology, 2004
- Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface diseaseBritish Journal of Ophthalmology, 2004
- Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplantation, 2003
- Treatment of persistent corneal epithelial defect by autologous serum applicationOphthalmology, 1999